{"id":"https://openalex.org/W1965775006","doi":"https://doi.org/10.1111/j.1600-0609.1995.tb01815.x","title":"COP\u2010BLAM regimen combined with granulocyte colony\u2010stimulating factor and high\u2010grade non\u2010Hodgkin's lymphoma","display_name":"COP\u2010BLAM regimen combined with granulocyte colony\u2010stimulating factor and high\u2010grade non\u2010Hodgkin's lymphoma","publication_year":1995,"publication_date":"1995-08-01","ids":{"openalex":"https://openalex.org/W1965775006","doi":"https://doi.org/10.1111/j.1600-0609.1995.tb01815.x","mag":"1965775006","pmid":"https://pubmed.ncbi.nlm.nih.gov/7543059"},"language":"en","primary_location":{"id":"doi:10.1111/j.1600-0609.1995.tb01815.x","doi":"https://doi.org/10.1111/j.1600-0609.1995.tb01815.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0609.1995.tb01815.x","pdf_url":null,"source":{"id":"https://openalex.org/S159715054","display_name":"European Journal Of Haematology","issn_l":"0902-4441","issn":["0902-4441","1600-0609"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Haematology","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5051372277","display_name":"Nozomi Niitsu","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129634264","display_name":"Toho University","ror":"https://ror.org/02hcx7n63","country_code":"JP","type":"education","lineage":["https://openalex.org/I129634264"]}],"countries":["JP"],"is_corresponding":true,"raw_author_name":"N. Niitsu","raw_affiliation_strings":["First Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"First Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan","institution_ids":["https://openalex.org/I129634264"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5078749313","display_name":"Masanori Umeda","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I129634264","display_name":"Toho University","ror":"https://ror.org/02hcx7n63","country_code":"JP","type":"education","lineage":["https://openalex.org/I129634264"]}],"countries":["JP"],"is_corresponding":false,"raw_author_name":"M. Umeda","raw_affiliation_strings":["First Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"First Department of Internal Medicine, Toho University School of Medicine, Tokyo, Japan","institution_ids":["https://openalex.org/I129634264"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":1,"corresponding_author_ids":["https://openalex.org/A5051372277"],"corresponding_institution_ids":["https://openalex.org/I129634264"],"apc_list":{"value":4650,"currency":"USD","value_usd":4650},"apc_paid":null,"fwci":0.5706,"has_fulltext":false,"cited_by_count":9,"citation_normalized_percentile":{"value":0.69132231,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":null,"biblio":{"volume":"55","issue":"2","first_page":"88","last_page":"92"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9643999934196472,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T10185","display_name":"Lymphoma Diagnosis and Treatment","score":0.9643999934196472,"subfield":{"id":"https://openalex.org/subfields/2734","display_name":"Pathology and Forensic Medicine"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12172","display_name":"Neutropenia and Cancer Infections","score":0.027799999341368675,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T11157","display_name":"Chronic Lymphocytic Leukemia Research","score":0.003000000026077032,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/granulocyte-colony-stimulating-factor","display_name":"granulocyte colony-stimulating factor","score":0.9549999833106995},{"id":"https://openalex.org/keywords/non-hodgkin-lymphoma","display_name":"non-Hodgkin lymphoma","score":0.9810000061988831},{"id":"https://openalex.org/keywords/high-grade-lymphoma","display_name":"high-grade lymphoma","score":0.6819999814033508},{"id":"https://openalex.org/keywords/complete-remission","display_name":"complete remission","score":0.7559999823570251},{"id":"https://openalex.org/keywords/survival","display_name":"survival","score":0.7450000047683716},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.9599999785423279},{"id":"https://openalex.org/keywords/serum-lactate-dehydrogenase","display_name":"serum lactate dehydrogenase","score":0.8389999866485596},{"id":"https://openalex.org/keywords/c-reactive-protein","display_name":"C-reactive protein","score":0.8640000224113464},{"id":"https://openalex.org/keywords/interstitial-lung-disease","display_name":"interstitial lung disease","score":0.7149999737739563},{"id":"https://openalex.org/keywords/adverse-effects","display_name":"adverse effects","score":0.4740000069141388},{"id":"https://openalex.org/keywords/treatment-naive-patients","display_name":"treatment-naive patients","score":0.699999988079071}],"concepts":[{"id":"https://openalex.org/C2781413609","wikidata":"https://www.wikidata.org/wiki/Q7308373","display_name":"Regimen","level":2,"score":0.6283292174339294},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.6160535216331482},{"id":"https://openalex.org/C2779338263","wikidata":"https://www.wikidata.org/wiki/Q208414","display_name":"Lymphoma","level":2,"score":0.5553911924362183},{"id":"https://openalex.org/C2777767877","wikidata":"https://www.wikidata.org/wiki/Q419327","display_name":"Granulocyte colony-stimulating factor","level":3,"score":0.5200836062431335},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.4615061581134796},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.45954862236976624},{"id":"https://openalex.org/C2778476748","wikidata":"https://www.wikidata.org/wiki/Q1138590","display_name":"Non-Hodgkin's lymphoma","level":3,"score":0.43247556686401367},{"id":"https://openalex.org/C502942594","wikidata":"https://www.wikidata.org/wiki/Q3421914","display_name":"Cancer research","level":1,"score":0.35569751262664795},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.26778385043144226}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000369","descriptor_name":"Aged, 80 and over","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001761","descriptor_name":"Bleomycin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D001761","descriptor_name":"Bleomycin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004317","descriptor_name":"Doxorubicin","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005334","descriptor_name":"Fever","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007239","descriptor_name":"Infections","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D008228","descriptor_name":"Lymphoma, Non-Hodgkin","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009503","descriptor_name":"Neutropenia","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011241","descriptor_name":"Prednisone","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011241","descriptor_name":"Prednisone","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011344","descriptor_name":"Procarbazine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D011344","descriptor_name":"Procarbazine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D011994","descriptor_name":"Recombinant Proteins","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D012074","descriptor_name":"Remission Induction","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D014750","descriptor_name":"Vincristine","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":true},{"descriptor_ui":"D016179","descriptor_name":"Granulocyte Colony-Stimulating Factor","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1111/j.1600-0609.1995.tb01815.x","doi":"https://doi.org/10.1111/j.1600-0609.1995.tb01815.x","is_oa":false,"landing_page_url":"https://doi.org/10.1111/j.1600-0609.1995.tb01815.x","pdf_url":null,"source":{"id":"https://openalex.org/S159715054","display_name":"European Journal Of Haematology","issn_l":"0902-4441","issn":["0902-4441","1600-0609"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-70","russia-white-list-2","vabb-shw"],"host_organization":"https://openalex.org/P4310320595","host_organization_name":"Wiley","host_organization_lineage":["https://openalex.org/P4310320595"],"host_organization_lineage_names":["Wiley"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European Journal of Haematology","raw_type":"journal-article"},{"id":"pmid:7543059","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/7543059","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"European journal of haematology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Clinical Trial","id":"https://openalex.org/study-designs/clinical-trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":false,"pdf":false},"content_urls":null,"referenced_works_count":13,"referenced_works":["https://openalex.org/W201280849","https://openalex.org/W850470413","https://openalex.org/W1529388857","https://openalex.org/W1874309326","https://openalex.org/W1979300931","https://openalex.org/W2073151455","https://openalex.org/W2093159499","https://openalex.org/W2153455196","https://openalex.org/W2318772898","https://openalex.org/W2413877714","https://openalex.org/W2414993396","https://openalex.org/W2462754346","https://openalex.org/W3041047318"],"related_works":["https://openalex.org/W2406134648","https://openalex.org/W2395495313","https://openalex.org/W2102844960","https://openalex.org/W2333839697","https://openalex.org/W2587521265","https://openalex.org/W1529388857","https://openalex.org/W3041694711","https://openalex.org/W7098559571","https://openalex.org/W2332664345","https://openalex.org/W329572921"],"abstract_inverted_index":{"The":[0,118,134,175],"clinical":[1,97,116],"efficacy":[2],"of":[3,29,55,73,75,109,121,123,137,156,163,196],"COP-BLAM":[4,35,148,182],"chemotherapy":[5],"combined":[6,149,180],"with":[7,21,69,84,102,150,181],"human":[8],"recombinant":[9],"granulocyte":[10,47],"colony-stimulating":[11],"factor":[12],"(G-CSF)":[13],"was":[14,37,43,67,79,125,183],"evaluated":[15],"in":[16,82,95,100,114,172,185],"104":[17,56],"previously":[18],"untreated":[19],"patients":[20,58,83,101,129,168,190],"non-Hodgkin's":[22],"lymphoma":[23],"(NHL).":[24],"According":[25],"to":[26],"the":[27,46,63,167,189,197],"method":[28],"Laurence":[30],"et":[31],"al.,":[32],"a":[33,60,70,153,160,193],"modified":[34],"regimen":[36],"administered":[38,147],"every":[39],"21":[40],"days.":[41,127],"G-CSF":[42,124,138,151,179],"added":[44],"when":[45],"count":[48],"fell":[49],"below":[50],"1000":[51],"x":[52],"10(9)/l.":[53],"Ninety-eight":[54],"(94.2%)":[57],"achieved":[59,152],"complete":[61],"remission;":[62],"4-year":[64],"survival":[65],"rate":[66,155],"82.4%":[68],"median":[71],"duration":[72,120],"observation":[74],"26":[76],"months.":[77],"Survival":[78],"significantly":[80],"longer":[81],"low":[85,92,161],"serum":[86,104],"LDH":[87,105],"levels,":[88,106],"B-cell":[89],"type":[90,108],"or":[91,94,113],"CRP":[93,111],"earlier":[96],"stages,":[98],"than":[99],"high":[103,154],"T-cell":[107],"higher":[110,194],"levels":[112],"advanced":[115],"stages.":[117],"mean":[119],"administration":[122],"5.4":[126],"Twelve":[128],"developed":[130],"infections":[131],"during":[132],"treatment.":[133],"adverse":[135],"effects":[136],"included":[139],"interstitial":[140],"pneumonia,":[141],"bone":[142],"pain":[143],"and":[144,158],"fever.":[145],"Patients":[146],"remission":[157],"had":[159],"incidence":[162],"infection.":[164],"Nearly":[165],"all":[166],"could":[169],"be":[170],"treated":[171],"21-day":[173],"cycles.":[174],"results":[176],"suggest":[177],"that":[178],"effective":[184],"treating":[186],"NHL,":[187],"because":[188],"can":[191],"tolerate":[192],"dose":[195],"anticancer":[198],"agents.":[199]},"counts_by_year":[],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2016-06-24T00:00:00"}